Skip to main content
. 2011 Apr 30;4(1):1–7. doi: 10.14802/jmd.11001

Figure 1.

Figure 1

Illustration of the concept of virtual clinical trials as a method of predicting the efficacy of therapies to reduce SNCA expression of Parkinoson’s Disease.